{"disease":{"id":"duplication","name":"duplication"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT06930417","title":"Characterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 Variants","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT01694940","title":"North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT02705677","title":"Biobanking of Rett Syndrome and Related Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":752,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT01132885","title":"Defining the Brain Phenotype of Children With Williams Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":415,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT06708429","title":"Lynch Syndrome X-Talk of Enteral Mucosa With Immune System","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"San Raffaele University","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT03077308","title":"Rare Diseases Clinical Research Network: Neurophysiological Correlates","phase":"","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT06185400","title":"RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":108,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT02927262","title":"A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT01892371","title":"Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":true},{"nct_id":"NCT06377670","title":"Study of Functional and Aesthetic Outcomes After Wassel IV Thumb Duplication Surgery in Pediatric Population, With a Follow-up of at Least One Year","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT06014541","title":"Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome","phase":"","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"Ionis Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07259707","title":"Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT03694275","title":"A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04103333","title":"Angelman Syndrome (AS) Biomarker Study","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT07469566","title":"Characterization of the Natural History of Microduplication Syndrome 7q11.23","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04240002","title":"A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT06615206","title":"A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)","phase":"NA","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"HuidaGene Therapeutics Co., Ltd.","has_results":false},{"nct_id":"NCT02624570","title":"Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}